Vaccines against COVID-19, the seasonal flu and RSV are our best chance of preventing a winter surge

As cold and flu season ramps up, health care experts are once again on high alert for the possibility of a tripledemic, or a surge brought on by the respiratory…

FDA’s greenlighting of maternal RSV vaccine represents a major step forward in protecting young babies against the virus

With the Food and Drug Administration’s Aug. 21, 2023, approval of the first vaccine against respiratory syncytial virus, or RSV, for use during late pregnancy, the U.S. will soon have…

FDA’s approval of the world’s first vaccine against RSV will offer a new tool in an old fight – 4 questions answered

The U.S. Food and Drug Administration approved the world’s first vaccine to prevent the respiratory infection RSV, short for respiratory syncytial virus, on May 3, 2023. The new shot represents…